Intestinal vascular endothelial growth factor is decreased in necrotizing enterocolitis

Neonatology

Volumn 107, Issue 3, 2015, Pages 191-198

  Sabnis, Animesh ^a   Carrasco, Rosa ^a   Liu, Shirley X L ^a   Yan, Xiaocai ^a   Managlia, Elizabeth ^a   Chou, Pauline M ^c   Tan, Xiao Di ^b,c   De Plaen, Isabelle G ^a  

^a Division of Neonatology   (United States)

^b Division of Gastroenterology   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Animal; Animal model; Human; Necrotizing enterocolitis; Vascular endothelial growth factor A

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MILK; BACTERIA; CLINICAL PROTOCOL; COLD STRESS; COMMENSAL; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INOCULATION; INTERMITTENT HYPOXIA; INTESTINE; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; MOUSE; MYENTERIC PLEXUS; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUP (RODENT); STAINING; ANIMAL; C57BL MOUSE; COLD SHOCK RESPONSE; DISEASE MODEL; DOWN REGULATION; GENETICS; INFANT; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE;

ANIMALS; ANIMALS, NEWBORN; COLD-SHOCK RESPONSE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENTEROCOLITIS, NECROTIZING; HUMANS; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923098051     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000368879     Document Type: Article

References (27)

1. Fanaroff AA, Hack M, Walsh MC: The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol 2003; 27:281-287.
2. De Plaen IG: Inflammatory signaling in nec-rotizing enterocolitis. Clin Perinatol 2013; 40: 109-124.
3. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N: VEGF is required for growth and survival in neonatal mice. Development 1999; 126:1149-1159.
4. Siafakas CG, Anatolitou F, Fusunyan RD, Walker WA, Sanderson IR: Vascular endo-thelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res 1999; 45: 652-657.
5. Rossiter H, Barresi C, Ghannadan M, Gruber F, Mildner M, Fodinger D, Tschachler E: In-activation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. FASEB J 2007; 21:3994-4004.
6. Banyasz I, Bokodi G, Vasarhelyi B, Treszl A, Derzbach L, Szabo A, Tulassay T, Vannay A: Genetic polymorphisms for vascular endo-thelial growth factor in perinatal complications. Eur Cytokine Netw 2006; 17:266-270.
7. Cetinkaya M, Ozkan H, Koksal N: Maternal preeclampsia is associated with increased risk of necrotizing enterocolitis in preterm infants. Early Hum Dev 2012; 88:893-898.
8. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sell-ke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658.
9. Downard CD, Grant SN, Matheson PJ, Guil-laume AW, Debski R, Fallat ME, Garrison RN: Altered intestinal microcirculation is the critical event in the development of necrotiz-ing enterocolitis. J Pediatr Surg 2011; 46: 1023-1028.
10. Yu X, Radulescu A, Zorko N, Besner GE: Hep-arin-binding EGF-like growth factor increases intestinal microvascular blood flow in nec-rotizing enterocolitis. Gastroenterology 2009; 137:221-230.
11. Bergmann KR, Liu SX, Tian R, Kushnir A, Turner JR, Li HL, Chou PM, Weber CR, De Plaen IG: Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enteroco-litis. Am J Pathol 2013; 182:1595-1606.
12. Tian R, Liu SX, Williams C, Soltau TD, Dim-mitt R, Zheng X, De Plaen IG: Characterization of a necrotizing enterocolitis model in newborn mice. Int J Clin Exp Med 2010; 3: 293-302.
13. Hosford GE, Olson DM: Effects of hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol 2003; 285:L161-L168.
14. Been JV, Lievense S, Zimmermann LJ, Kramer BW, Wolfs TG: Chorioamnionitis as a risk factor for necrotizing enterocolitis: a systematic review and meta-analysis. J Pediatr 2013; 162:236-242.e2.
15. Liu SX, Tian R, Baskind H, Hsueh W, De Plaen IG: Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice. Am J Physiol Gastrointest Liver Physiol 2009; 297:G76-G81.
16. Nankervis CA, Giannone PJ, Reber KM: The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis. Semin Perinatol 2008; 32:83-91.
17. Nowicki PT, Dunaway DJ, Nankervis CA, Gi-annone PJ, Reber KM, Hammond SB, Besner GE, Caniano DA: Endothelin-1 in human intestine resected for necrotizing enterocolitis. J Pediatr 2005; 146:805-810.
18. Abman SH: Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. Adv Exp Med Biol 2010; 661:323-335.
19. Levesque BM, Kalish LA, Winston AB, Parad RB, Hernandez-Diaz S, Phillips M, Zolit A, Morey J, Gupta M, Mammoto A, Ingber DE, Van Marter LJ: Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopa-thy of prematurity. Neonatology 2013; 104: 56-64.
20. Tsao PN, Wei SC: Prenatal hypoxia downreg-ulates the expression of pulmonary vascular endothelial growth factor and its receptors in fetal mice. Neonatology 2013; 103:300-307.
21. Karatepe HO, Kilincaslan H, Berber M, Ozen A, Saricoban HE, Ustek D, Kemik AS, Adas M, Bakar F: The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis. Pediatr Surg Int 2014; 30:327-332.
22. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Kes-het E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995; 1:1024-1028.
23. Holmes K, Charnock Jones SD, Forhead AJ, Giussani DA, Fowden AL, Licence D, Kemp-ster S, Smith GC: Localization and control of expression of VEGF-A and the VEGFR-2 receptor in fetal sheep intestines. Pediatr Res 2008; 63:143-148.
24. Vuorela P, Andersson S, Carpen O, Ylikorka-la O, Halmesmaki E: Unbound vascular endo-thelial growth factor and its receptors in breast, human milk, and newborn intestine. Am J Clin Nutr 2000; 72:1196-1201.
25. Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA: Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig Liver Dis 2008; 40:673-679.
26. Frysz-Naglak D, Fryc B, Klimacka-Nawrot E, Mazurek U, Suchecka W, Kajor M, Kurek J, Stadnicki A: Expression, localization and systemic concentration of vascular endothelial growth factor (VEGF) and its receptors in patients with ulcerative colitis. Int Immuno-pharmacol 2011; 11:220-225.
27. Van Der Loos CM, Meijer-Jorna LB, Broek-mans ME, Ploegmakers HP, Teeling P, De Boer OJ, Van Der Wal AC: Anti-human vascular endothelial growth factor (VEGF) antibody selection for immunohistochemical staining of proliferating blood vessels. J His-tochem Cytochem 2010; 58:109-118.